Cargando…
Utility and safety of nafamostat mesilate for anticoagulation in dogs
BACKGROUND: Surgical interventions are recommended for cases of advanced mitral regurgitation, however, limited facilities are available. The most prominent complication in such procedures is heparin‐derived bleeding. An alternative anticoagulant to heparin, nafamostat mesilate (NM), can reduce the...
Autores principales: | Isayama, Noriko, Matsumura, Goki, Uchimura, Yusuke, Maeda, Erika, Sasaki, Kenta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856972/ https://www.ncbi.nlm.nih.gov/pubmed/36408760 http://dx.doi.org/10.1002/vms3.1002 |
Ejemplares similares
-
Use of Nafamostat Mesilate as an Anticoagulant during Extracorporeal Membrane Oxygenation
por: Han, Sang Jin, et al.
Publicado: (2011) -
Cardiac arrest caused by nafamostat mesilate
por: Kim, Hyo Shik, et al.
Publicado: (2016) -
The role of nafamostat mesilate as a regional anticoagulant during extracorporeal membrane oxygenation
por: Lee, Jae Ha, et al.
Publicado: (2022) -
Validation of Nafamostat Mesilate as an Anticoagulant in Extracorporeal Membrane Oxygenation: A Large-Animal Experiment
por: Han, Sung Joon, et al.
Publicado: (2018) -
Clinical utility of a new protocol of cardiac computed tomography in dogs
por: Kim, Junyoung, et al.
Publicado: (2022)